NASDAQ: FONR - FONAR Corporation

Rentabilität für sechs Monate: -6.96%
Sektor: Healthcare

Aktionsplan FONAR Corporation


Über das Unternehmen

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.

Weitere Details
The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 41 MRI scanning facilities, including 26 facilities located in New York and 15 facilities located in Florida. The company markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

Выручка 0.0872
EBITDA 0.0221
Число акций ао 0.00677 млрд
P/E 6.91
P/S 1.63
P/BV 1.2
EV/EBITDA 5.79
Цена ао 21.71
ISIN US3444374058
Сайт https://www.fonar.com
Див.доход ао 0.0486
Дивиденд ао 0.0076
Валюта usd
IPO date 1987-01-01
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Preisänderung pro Tag: 0% (15.64)
Preisänderung pro Woche: -1.01% (15.8)
Preisänderung pro Monat: -7.02% (16.82)
Preisänderung über 3 Monate: -12.48% (17.87)
Preisänderung über sechs Monate: -6.96% (16.81)
Preisänderung pro Jahr: +12.68% (13.88)
Preisänderung über 3 Jahre: +0.7083% (15.53)
Preisänderung über 5 Jahre: -35.53% (24.26)
Preisänderung seit Jahresbeginn: -6.63% (16.75)

Unterschätzung

Name Bedeutung Grad
P/S 0.9571 9
P/BV 0.6281 10
P/E 9.32 9
EV/EBITDA 3.21 10
Gesamt: 9.38

Effizienz

Name Bedeutung Grad
ROA, % 4.93 1
ROE, % 6.37 2
Gesamt: 3.17

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0.5 5
Gesamt: 1.48

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0.1461 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 20.05 4
Rentabilität Ebitda, % 90.5 9
Rentabilität EPS, % -8.36 0
Gesamt: 2.8

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
Avantis U.S. Small Cap Value ETF 0.00374 29.302558956347 2.3212
Dimensional U.S. Core Equity 2 ETF 0.00058 30.755198832543 1.47098
Dimensional U.S. Targeted Value ETF 0.00634 26.007247921552 1.93487
Dimensional US Small Cap Value ETF 0.00799 25.854782942758 1.97866
Dimensional U.S. Equity ETF 0.00011 31.530984204131 1.3557
iShares Micro-Cap ETF 0.0277 36.318555985322 1.54048



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Timothy R. Damadian M.D. Chairman, President, CEO & Treasurer 152.9k 1964 (60 Jahre)
Mr. Luciano B. Bonanni COO, Executive VP & Acting Principal Financial Officer 449.22k 1955 (69 Jahre)
Ms. Claudette J. V. Chan Secretary & Director 58.88k 1938 (86 Jahre)
Mr. Daniel Culver Director of Communications N/A

Adresse: United States, Melville. NY, 110 Marcus Drive - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.fonar.com